Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Alexander Satin

Orthopaedic Surgery of the Spine Plano, TX Medical Doctor

NPI 1942628227 CMS profile 4221041

6020 W Parker Rd Ste 200, Plano, TX 75093

Open in the dashboard

General payments

$82,657

187 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Alexander Satin of Plano, TX is reported in the CMS Open Payments database as having received $82,657 across 187 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 75th percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,610 48
2024 General $7,978 26
2023 General $7,361 26
2022 General $12,339 18
2021 General $3,623 14
2020 General $570 7
2019 General $13,175 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Alexander Satin
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Alexander Satin were reported at $37,610. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Alexander Satin Orthopaedic Surgery of the Spine median Middle half National median
2019 $13,175 $2,106 $337–$18,608 $163
2020 $570 $1,213 $156–$15,082 $114
2021 $3,623 $1,834 $271–$15,617 $132
2022 $12,339 $2,015 $320–$17,036 $149
2023 $7,361 $1,925 $336–$14,599 $160
2024 $7,978 $2,110 $341–$12,483 $164
2025 $37,610 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. DeGen Medical, Inc. $40,305 41 payments
  2. Centinel Spine, LLC $14,335 10 payments
  3. NuVasive, Inc. $10,624 21 payments
  4. Alphatec Spine, Inc $3,677 5 payments
  5. Kuros Biosciences USA, Inc $2,640 6 payments
  6. Orthofix Medical, Inc. $1,975 24 payments
  7. Circinus Medical Technology LLC $1,397 2 payments
  8. Medical Device Business Services, Inc. $1,303 11 payments
  9. Medtronic USA, Inc. $1,224 15 payments
  10. Globus Medical, Inc. $1,077 14 payments
  11. Other $4,099 38 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $36,869 14 payments
  2. Travel and Lodging $13,858 23 payments
  3. Food and Beverage $13,468 140 payments
  4. Royalty or License $10,443 8 payments
  5. Grant $8,000 1 payment
  6. Entertainment $19 1 payment
Products named General payments · program years 2019–2025
  1. ALIF Lumbar Interbody $18,037 9 payments
  2. PRODISC L $14,210 7 payments
  3. ALIF Lumbar Interbody System $7,821 5 payments
  4. Other - Miscellaneous $3,379 3 payments
  5. Cervical Stand Alone $2,300 1 payment
  6. Solar $2,156 2 payments
  7. MAGNETOS $1,977 5 payments
  8. XLIF $1,628 12 payments
  9. Bolt Navigation $1,397 2 payments
  10. EXPEDIUM $1,163 10 payments
  11. Other $11,725 127 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

167

Median for Orthopedic Surgery: 203

Drug cost

$1,237

Median for Orthopedic Surgery: $1,433

Branded share of claims

24.6%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 41 $596
Cyclobenzaprine Hcl Generic 24 $182
Methocarbamol Generic 22 $175
Gabapentin Generic 46 $163
Meloxicam Generic 17 $82
Tramadol Hcl Generic 17 $39

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 57 billing codes

Paid by Medicare

$169,985

Medicare's payments for the services billed

Medicare patients

236

Average age 74

Services billed

1,003

127 women, 109 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 33%
Depression 29%
Osteoporosis 27%
Diabetes 26%
Chronic kidney disease 22%
Atrial fibrillation 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

187 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record